Whilst some international locations, significantly these first hit by the coronavirus, present some constructive indicators of enchancment, the Wor
Whilst some international locations, significantly these first hit by the coronavirus, present some constructive indicators of enchancment, the World Well being Group has warned that the pandemic continues to be worsening around the globe. Most day by day new instances are coming from 10 international locations, in response to the WHO, principally within the Americas and South Asia.
Within the U.S., the New York Metropolis area, which was the preliminary epicenter of the nation’s outbreak, has seen the day by day progress of its epidemic decline considerably, and officers have begun to ease restrictions. Nonetheless, some states that had been among the many first to reopen have begun to see indicators that their outbreaks are worsening.
That is CNBC’s stay weblog protecting all the most recent information on the coronavirus outbreak. This weblog can be up to date all through the day because the information breaks.
- World instances: Greater than 7.1 million
- World deaths: Not less than 406,925
- U.S. instances: Greater than 1.9 million
- U.S. deaths: Not less than 111,007
The information above was compiled by Johns Hopkins College.
Retail retailer closures may speed up to as many as 25,000 in 2020
A retailer stands closed close to Wall Avenue because the coronavirus retains monetary markets and companies principally closed on Could 08, 2020 in New York Metropolis.
Spencer Platt | Getty Photographs
9:15 a.m. ET — Because the coronavirus pandemic takes a toll on many retailers’ companies, there might be as many as 25,000 retailer closures introduced by these firms this yr, in response to one agency.
U.S. retailers may announce between 20,000 and 25,000 closures in 2020, in response to monitoring by Coresight Analysis, with 55% to 60% of these located in America’s malls. That might additionally mark a brand new file — which was beforehand greater than 9,300 areas in 2019.
Chapter filings by retailers have began to mount, and Coresight expects extra are on the best way.
“We count on {that a} return to pre-crisis ranges in offline discretionary retail gross sales total can be gradual, as we count on shopper confidence, demand and spending to be in need of regular for a while,” Coresight founder and CEO Deborah Weinswig stated within the report. —Lauren Thomas
The most recent U.S. scorching spots
Macy’s says reopening shops are performing higher than expectations, shares soar
A view exterior Macy’s Herald Sq. throughout the coronavirus pandemic on Could 13, 2020 in New York Metropolis.
Noam Galai | Getty Photographs
8:17 a.m. ET — Macy’s shares are rising after the corporate launched its preliminary monetary outcomes, saying prospects are returning to reopened shops a lot quicker than it anticipated. The division retailer operator can also be telling analysts and traders it ought to enter the vacation season later this yr within the lean stock place. Shares had been lately up greater than 9% in premarket buying and selling.
With the retailer’s shops shut for many of its fiscal first quarter as a result of coronavirus pandemic, gross sales are anticipated to fall 45% to $3.02 billion from $5.5 billion a yr in the past, Macy’s stated. Additionally it is forecasting a quarterly internet lack of $652 million, or $2.10 per share, for the interval ended Could 2, in contrast with internet earnings of $136 million, or 44 cents a share, in the identical interval a yr prior.
As of June 1, Macy’s stated it had roughly 450 areas again up and operating. The corporate additionally on Monday night introduced it has raised $4.5 billion in new financing, giving it “ample liquidity” to climate the coronavirus disaster. —Lauren Thomas
Engagement ring gross sales dropped off steeply throughout pandemic, Tiffany & Co says
8:10 a.m. ET — As folks throughout the globe stayed dwelling throughout the pandemic, Tiffany & Co noticed a pointy drop off in gross sales — particularly for engagement rings.
The posh jewellery firm stated same-store gross sales had been down by about 44% throughout its fiscal first quarter, as most of its 324 shops quickly closed. Its largest decline was in engagement jewellery, which plummeted by almost 50%
Tiffany stated gross sales are gaining steam once more, particularly in China. Gross sales within the nation jumped by 30% throughout April and about 90% in Could, in contrast with the identical interval a yr prior. And, it stated, its new assortment of rose gold and gold with diamonds is catching prospects’ eyes. —Melissa Repko
U.S. probably will not shut down once more even when instances rise after reopening, Gottlieb says
Remdesivir research on monkeys reveals drug decreased lung harm
Lab technicians load stuffed vials of investigational coronavirus illness (COVID-19) remedy drug remdesivir at a Gilead Sciences facility in La Verne, California, U.S. March 18, 2020. Image taken March 18, 2020.
Gilead Sciences Inc | Reuters
7:42 a.m. ET — Gilead Sciences antiviral drug remdesivir helped to stop macaques contaminated with the coronavirus from growing respiratory illness and decreased lung harm related to the virus, in response to a brand new research revealed within the medical journal Nature.
The research concerned 12 monkeys contaminated with the coronavirus, with solely six of them given remdesivir intravenously early on within the research. Those who acquired the drug didn’t develop respiratory illness and suffered much less lung harm, the research confirmed.
“Our information help early remdesivir remedy initiation in Covid-19 sufferers to stop development to pneumonia,” the authors stated within the report. The drug didn’t seem to cut back the infectiousness of the contaminated animals, nevertheless.
“Regardless of the shortage of apparent respiratory indicators and decreased virus replication within the lungs of remdesivir-treated animals, there was no discount in virus shedding,” the research stated. Scientific trials involving people are ongoing. —Holly Ellyatt
AstraZeneca ramps up research for antibody remedies
A pedestrian walks previous signage exterior an AstraZeneca Plc analysis and improvement facility in Shanghai, China, on Monday, June 8, 2020.
Qilai Shen | Bloomberg | Getty Photographs
7:05 a.m. ET — British drugmaker AstraZeneca expects to maneuver two potential Covid-19 antibody-based therapeutics into scientific trials within the subsequent two months, the corporate introduced.
AstraZeneca stated it licensed the antibodies from Vanderbilt College and hopes to develop them into a possible mixture remedy for each the prevention and remedy of Covid-19.
The corporate, which is already engaged on a possible coronavirus vaccine, additionally stated it has signed agreements with the U.S. Protection Superior Analysis Tasks Company and the U.S. Biomedical Superior Analysis and Improvement Authority to help improvement of the potential remedies. —Will Feuer
Learn CNBC’s earlier coronavirus stay protection right here: Brazil faces criticism over information; Germany reviews file plunge in exports